Localized myxedema in Grave's disease confined to the toes.
Katsambas
A
A
Pantazi
V
V
Giannakopoulou
H
H
Potouridou
I
I
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002990:Clobetasol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005534:Foot Diseases / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005938:Glucocorticoids; D006111:Graves Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009230:Myxedema / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D014034:Toes / Q000473:pathology*
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D002990:Clobetasol